Loading...
Ansell Limited
ANSLY•PNK
Healthcare
Medical - Instruments & Supplies
$79.49
$0.00(0.00%)
Ansell Limited (ANSLY) Financial Performance & Statements
Review Ansell Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.90%
↓ 0.90%
Operating Income Growth
-34.32%
↓ 34.32%
Net Income Growth
-48.42%
↓ 48.42%
Operating Cash Flow Growth
68.38%
↑ 68.38%
Operating Margin
10.08%
↑ 10.08%
Gross Margin
38.88%
↑ 38.88%
Net Profit Margin
4.52%
↑ 4.52%
ROE
4.40%
↑ 4.40%
ROIC
6.62%
↑ 6.62%
Ansell Limited (ANSLY) Financial Statements
Explore quarterly and annual reports for Ansell Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $834.40M | $784.90M | $816.27M | $409.90M |
| Cost of Revenue | $508.20M | $486.30M | $508.40M | $254.35M |
| Gross Profit | $326.20M | $298.60M | $307.87M | $155.55M |
| Gross Profit Ratio | $0.39 | $0.38 | $0.38 | $0.38 |
| R&D Expenses | $16.60M | $0.00 | $8.95M | $8.95M |
| SG&A Expenses | $208.90M | $220.40M | $190.88M | $96.80M |
| Operating Expenses | $236.40M | $259.10M | $190.88M | $97.55M |
| Total Costs & Expenses | $744.60M | $745.40M | $699.28M | $351.90M |
| Interest Income | $0.00 | $1.88M | $1.28M | $4.35M |
| Interest Expense | $0.00 | $12.63M | $11.31M | $0.00 |
| Depreciation & Amortization | $22.00M | $25.10M | $34.15M | $10.50M |
| EBITDA | $139.30M | $103.30M | $152.44M | $69.25M |
| EBITDA Ratio | $0.17 | $0.13 | $0.19 | $0.17 |
| Operating Income | $89.80M | $39.50M | $116.99M | $58.75M |
| Operating Income Ratio | $0.11 | $0.05 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | -$10.30M | -$10.30M | -$10.16M | -$5.10M |
| Income Before Tax | $79.50M | $29.20M | $106.84M | $53.65M |
| Income Before Tax Ratio | $0.10 | $0.04 | $0.13 | $0.13 |
| Income Tax Expense | $22.00M | $9.20M | $11.10M | $11.10M |
| Net Income | $57.10M | $19.40M | $42.20M | $42.20M |
| Net Income Ratio | $0.07 | $0.02 | $0.05 | $0.10 |
| EPS | $0.43 | $0.15 | $0.33 | $0.33 |
| Diluted EPS | $0.43 | $0.15 | $0.33 | $0.33 |
| Weighted Avg Shares Outstanding | $132.93M | $125.97M | $127.11M | $127.11M |
| Weighted Avg Shares Outstanding (Diluted) | $132.90M | $125.90M | $127.10M | $127.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan